Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
12 drugs in development
By Therapeutic Area
top 6
R&D Momentum
92/100
Pipeline Velocity
70/100
Trial Completion Rate
76/100
Pipeline Concentration
17/100
Pipeline Freshness
75/100
Strategic Signals
Activity
Last 14 days
Plasticity of Motor Systems in Early Stage Parkinson's Disease
Tanzabilities Aim 3: Randomized Controlled Trial of a Sexual and Reproductive Health Curriculum for Persons With Disabilities
High-Intensity Interval Training and Moderate-Intensity Continuous Training in Reducing Atrial Fibrillation Burden
Myofunctional Therapy for Obstructive Sleep Apnea
Contingency Management as a Treatment for Opioid Use Disorder and Stimulant Use Disorder in a Primary Care Setting
Transdiagnostic Cognitive Biomarkers
The Effect of Regular Consumption of Intermediate Wheatgrass-Based Products on Measures of Gut Health
Evaluating the Effects of Reproductive Health Training on Provider Behavior - Aim 3
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)